Ezetimibe is an active pharmaceutical ingredient that functions as a cholesterol absorption inhibitor. It is used to lower total plasma cholesterol by inhibiting the intestinal absorption of cholesterol.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 163222-33-1
(3R,4S)-3-[(3S)-3-(4-Fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-1-phenylazetidin-2-one
pharmaceutical intermediate
Ceritinib D7
pharmaceutical raw material
Sitafloxacin hydrate (2:3)
pharmaceutical raw material
((plusmn))-Zanubrutinib
pharmaceutical raw material
Teriflunomide
pharmaceutical raw material
(4S)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
pharmaceutical raw material
(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
OLNTVTPDXPETLC-XPWALMASSA-N
C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O